SCHEMBL21155441

SCHEMBL21155441

Nc1cc2scnc2cc1O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DYRK1A Q13627 1/20 0.42
NPC1 O15118 4/20 0.41
RAB9A P51151 4/20 0.41
L3MBTL1 Q9Y468 3/20 0.41
KDM4E B2RXH2 2/20 0.41
HKDC1 Q2TB90 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
ALDH1A1 P00352 3/20 0.38
HSD17B10 Q99714 2/20 0.38
VRK1 Q99986 1/20 0.37
DAO P14920 1/20 0.33
HIF1A Q16665 1/20 0.33
GFER P55789 1/20 0.33
MEN1 O00255 3/20 0.32
KMT2A Q03164 3/20 0.32
GAA P10253 2/20 0.32
MAPT P10636 1/20 0.32
PKM P14618 1/20 0.32
RIPK2 O43353 2/20 0.32
LCK P06239 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19988679 0.92 DYRK1A (0.42) DYRK1ANPC1RAB9AL3MBTL1KDM4E
SCHEMBL6031739 0.83 NPC1 (0.46) DYRK1ANPC1RAB9AL3MBTL1KDM4E
SCHEMBL15689087 0.76 DYRK1A (0.42) DYRK1ANPC1RAB9AL3MBTL1KDM4E
SCHEMBL22304452 0.76 DYRK1A (0.42) DYRK1ANPC1RAB9AL3MBTL1KDM4E
SCHEMBL13166359 0.76 DYRK1A (0.42) DYRK1ANPC1RAB9AL3MBTL1KDM4E
SCHEMBL4055332 0.76 NPC1 (0.41) DYRK1ANPC1RAB9AL3MBTL1KDM4E
SCHEMBL4296143 0.75 ALDH1A1 (0.52) DYRK1ANPC1RAB9AL3MBTL1KDM4E
SCHEMBL12228882 0.74 DYRK1A (0.38) DYRK1ANPC1RAB9AL3MBTL1KDM4E
SCHEMBL1420652 0.73 GAA (0.44) DYRK1ANPC1RAB9AL3MBTL1KDM4E
SCHEMBL4560336 0.73 ALDH1A1 (0.50) DYRK1ANPC1RAB9AL3MBTL1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3512848-B1 COMPOUNDS WITH CARBAZOLE STRUCTURES MERCK PATENT GMBH (DE) 2020-11-18 EP disclosed
US-20190214574-A1 COMPOUNDS WITH CARBAZOLE STRUCTURES MERCK PATENT GMBH (DE) 2019-07-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190214574-A1 COMPOUNDS WITH CARBAZOLE STRUCTURES CYCS, CYP3A4, CYP2E1 DYRK1A 3310/4885NPC1 754/4885RAB9A 2257/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.